Finance

Lists
4883:TYO
Modalis Therapeutics Corp
¥31.00
0.00%
(0.00) 1D
Oct 1, 2:21:02 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4883...
Open
¥32
High
¥32
Low
¥31
Mkt. cap
3.44B
Avg. vol.
2.32M
Volume
137.30K
52-wk high
¥83
52-wk low
¥29
EPS
-¥24
No. of employees
17
Open
¥32
High
¥32
Low
¥31
Mkt. cap
3.44B
Avg. vol.
2.32M
Volume
137.30K
52-wk high
¥83
52-wk low
¥29
EPS
-¥24
No. of employees
17
News stories
From web sources and news partners
About Modalis Therapeutics Corp
CEOHaru Morita
Employees17
FoundedJan 14, 2016
Headquarters-
SectorBiotechnology
Websitemodalistx.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
726.27M
346.41M
293.75M
606.25M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
56.81M
24.56M
48.78M
40.22M
Operating expense
783.08M
395.97M
342.52M
610.48M
Total operating expenses
783.08M
395.97M
342.52M
610.48M
Operating income
-783.08M
-395.97M
-342.52M
-610.48M
Other non operating income
-2.52M
11.62M
5.81M
29.19M
EBT including unusual items
-780.69M
-350.53M
-323.15M
-579.85M
EBT excluding unusual items
-779.04M
-350.77M
-322.51M
-596.49M
Income tax expense
625.00K
-300.00K
582.00K
5.42M
Effective tax rate
-0.08%
0.09%
-0.18%
-0.93%
Other operating expenses
-
25.00M
-
-
Net income
-781.32M
-350.23M
-323.73M
-585.27M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
2.53M
439.00K
2.25M
-
Interest expense
-7.92M
-839.00K
-2.34M
-6.91M
Net interest expenses
-5.39M
-400.00K
-86.00K
-6.91M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps